F-1/A: Ultratrex Amends F-1, Files Legal Opinions for IPO

Sentiment:

IPO Registration Statement Amendment


Ultratrex Inc. filed an amendment to its F-1 registration statement, primarily adding legal opinions and a waiver request for financial statement timing ahead of its proposed Nasdaq IPO.

Delay expectedThe company is requesting a waiver from the SEC's 12-month audited financial statement requirement for its initial public offering, indicating that the most recent audited financials (for the fiscal year ended June 30, 2025) are not yet available.The audited financial statements for the fiscal year ended June 30, 2025, are not anticipated to be available until October 31, 2025.The company will delay the effective date of the Registration Statement until a further amendment is filed or the SEC determines effectiveness, implying the IPO cannot proceed until these financial statements are ready and the waiver is granted or the 15-month rule is met.
Capital raiseThe filing is an amendment to a Form F-1 Registration Statement, which is used by foreign private issuers to register securities for an initial public offering (IPO) in the United States.The offering involves the sale of 1,250,000 Class A Ordinary Shares to the public.Underwriters will be granted an option to purchase up to an additional 15% of the Public Offering Shares to cover over-allotments.Non-redeemable warrants to purchase 6% of the IPO shares will be issued to the underwriters as compensation.

Summary

  • Amendment No. 1 to Form F-1 was filed on September 17, 2025, by Ultratrex Inc., a Cayman Islands exempted company.
  • The primary purpose of this amendment is to file new exhibits, including legal opinions and consents, and to amend and restate the exhibit index.
  • No changes have been made to the public offering prospectus, which remains as filed in the original Registration Statement on September 8, 2025.
  • The proposed offering involves 1,250,000 Class A Ordinary Shares, with an additional option for underwriters to purchase up to 15% of these shares to cover over-allotments.
  • Non-redeemable warrants to purchase Class A Ordinary Shares equal to 6% of the IPO Shares will be issued to the representative of the underwriters as compensation.
  • Legal opinions from Ogier (Cayman Islands counsel) confirm the company's due incorporation, good standing, and that the IPO Shares and Warrant Shares, when issued and paid for, will be validly issued, fully paid, and non-assessable.
  • Ortoli Rosenstadt (U.S. counsel) provided an opinion that the Underwriters Warrants, when issued, will be valid and legally binding obligations of the Company under New York law.
  • Malaysian, Indonesian, and Japanese legal counsels (Enolil Loo LLP, ABNR, and Tonogai Law, respectively) confirmed the accuracy and fair presentation of statements in the Registration Statement pertaining to their respective national laws.
  • Ultratrex Inc. has requested a waiver from the SEC's Item 8.A.4 of Form 20-F, which requires audited financial statements not older than 12 months for an initial public offering, citing impracticability and undue hardship.
  • The company's audited consolidated financial statements currently cover periods up to June 30, 2024, prepared under IFRS.
  • Audited financial statements for the fiscal year ended June 30, 2025, are anticipated to be available by October 31, 2025.
  • Ultratrex Inc. has committed to not seeking effectiveness of the Registration Statement if its audited financial statements are older than 15 months at the time of the initial public offering.

Sentiment

Score: 7

Explanation: The filing is a positive procedural step towards an IPO, confirming legal readiness and addressing a common financial reporting timing issue for foreign issuers. While the waiver request indicates a delay in having the absolute latest financials, the commitment to the 15-month rule is standard and expected, maintaining a generally positive outlook on the IPO progression.

Positives

  • Legal opinions from multiple jurisdictions confirm the validity of the Class A Shares and underwriters' warrants, ensuring legal compliance for the IPO.
  • The company is confirmed to be duly incorporated, validly existing, and in good standing under Cayman Islands law.
  • Corporate actions required for the issuance and sale of IPO Shares and Underwriters Warrants have been duly authorized.
  • The company is actively addressing SEC compliance requirements, including a waiver request for financial statement timing, demonstrating proactive management of the IPO process.

Risks

  • The effect and impact of the recently enacted Omnibus Law on job creation in Indonesia are not immediately known and subject to ongoing review.
  • The company may be subject to litigation, arbitration, or other legal proceeding risks.
  • The company's insurance coverage may be inadequate to protect it from potential losses.
  • The company may be affected by uncertainty in the balance of power between local governments and the central government in Indonesia.

Future Outlook

The company anticipates its audited financial statements for the fiscal year ended June 30, 2025, will be available by October 31, 2025. It has committed to not seeking effectiveness of the Registration Statement if its audited financial statements are older than 15 months at the time of the initial public offering.

Management Comments

  • The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
  • The Company is not required by any jurisdiction outside the United States to prepare consolidated financial statements audited under any generally accepted auditing standards for any interim period.
  • Full compliance with Item 8.A.4 of Form 20-F at present is impracticable and involves undue hardship for the Company.
  • The Company does not anticipate that its audited financial statements for the fiscal year ended June 30, 2025 will be available until October 31, 2025.
  • In no event will the Company seek effectiveness of the Registration Statement if its audited financial statements are older than 15 months at the time of the Companys initial public offering.

Industry Context

This filing represents a standard procedural step for a foreign private issuer preparing for an initial public offering on a U.S. exchange. The involvement of legal counsels from multiple Asian jurisdictions (Malaysia, Indonesia, Japan) suggests a business with significant international operations or market interests, aligning with broader trends of globalized capital markets and cross-border listings.

Legal Proceedings

  • The Indonesian legal opinion highlights a risk that the company may be subject to litigation, arbitration, or other legal proceeding risks.

Stakeholder Impact

  • **Future Shareholders:** Will gain legal title to validly issued, fully paid, and non-assessable Class A Shares upon the completion of the IPO.
  • **Underwriters:** Will receive compensation in the form of warrants and have an over-allotment option, indicating their active role in facilitating the capital raise.
  • **Prospective Investors:** Provided with legal assurances regarding the validity of the shares and warrants, and transparency regarding the timing of financial statement disclosures, aiding in their due diligence.

Next Steps

  • File further amendments to the Registration Statement as necessary to comply with SEC requirements.
  • Await the effective date of the Registration Statement as determined by the SEC.
  • Issue and sell the 1,250,000 Class A Ordinary Shares and the Underwriters Warrants upon the IPO's effectiveness.
  • Make audited financial statements for the fiscal year ended June 30, 2025, available by October 31, 2025.

Key Dates

DateDescription
August 15, 2024Date of incorporation of Ultratrex Inc.
April 22, 2025Date of written resolutions by the sole director approving the filing of the Registration Statement and issuance/sale of IPO Shares, Representative's Warrants, and Warrant Shares.
August 26, 2025Date of good standing certificate issued by the Registrar of Companies of the Cayman Islands.
September 5, 2025Date of written resolutions by the sole director approving the filing of the Registration Statement and issuance/sale of IPO Shares, Representative's Warrants, and Warrant Shares.
September 8, 2025Original F-1 Registration Statement filed with the U.S. Securities and Exchange Commission.
September 17, 2025Amendment No. 1 to Form F-1 filed with the U.S. Securities and Exchange Commission.
October 31, 2025Anticipated date for the availability of audited financial statements for the fiscal year ended June 30, 2025.

Recommendation

hold

This filing is a procedural amendment to an IPO registration statement, primarily adding legal opinions and a waiver request for financial statement timing. It does not contain new financial results, operational updates, or strategic shifts that would warrant an immediate 'buy' or 'sell' recommendation. It confirms the company is progressing towards its IPO, which is an expected event. An investor would 'hold' their current position or 'wait' for the full prospectus and pricing details before making an investment decision.

Keywords

Ultratrex, F-1/A, SEC filing, IPO, Nasdaq, Class A Shares, Underwriters Warrants, Legal Opinion, Cayman Islands, Malaysia, Indonesia, Japan, Financial Statements, Waiver Request, Capital Market

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.